These results, together with a past report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 guidance the concept of concentrating on ACKR3 as a unique technique to modulate the opioid method, which could open new therapeutic avenues for opioid-linked Problems.We independently exploration, critique, an